ZTI-01 Treatment Improves Survival of Animals Infected with Multidrug Resistant Pseudomonas aeruginosa

BACKGROUND: ZTI-01 (fosfomycin, FOS, for injection) is currently under US development to treat complicated urinary tract infections. ZTI-01 is unique compared with other antimicrobials in that it inhibits an early step in cell wall synthesis via covalent binding to MurA. ZTI-01 demonstrates broad in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawrenz, Matthew B, denDekker, Ashley Eb, Cramer, Daniel E, Gabbard, Jon D, Lafoe, Kathryn M, Pfeffer, Tia L, Sotsky, Julie B, Vanover, Carol D, Ellis-Grosse, Evelyn J, Warawa, Jonathan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631034/
http://dx.doi.org/10.1093/ofid/ofx163.1213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631034/
http://dx.doi.org/10.1093/ofid/ofx163.1213

Ejemplares similares